Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use


Article content

JAKARTA — Indonesia has approved the

single-dose COVID-19 vaccines produced by Janssen Pharmaceutical

Companies, part of Johnson & Johnson, and China’s CanSino

Biological Inc for emergency use, the country’s food and drug

agency said in a statement on Tuesday.

(Reporting by Stanley Widianto; Writing by Gayatri Suroyo

Editing by Ed Davies)